Prevalence, Risk Factors, and Management of Stroke in Patients with COVID-19 Infection: A Review
Journal of Advances in Medical and Pharmaceutical Sciences,
In the current pandemic, it is imperative to comprehend and advance a search forward to explore the pathogenesis of stroke in COVID-19 infected patients. In this review, we have discussed the prevalence of stroke in COVID-19 infected patients and different risk factors associated with the stroke in COVID-19. We also presented a comprehensive review on management of Stroke Patients during the COVID-19 pandemic. The COVID-19 positive patients with stroke should be treated in a designated COVID-19 health care center as per the guidelines. Study also showed that older patients with a history of cardiovascular diseases, prothrombotic state, smoking, and infection significantly had a higher likelihood of stroke incidence. The study revealed that effective treatment of COVID-19 and reduction of the inflammatory conditions may seem to be the way forward to minimize the symptomatic stroke associated with COVID-19 infection, and rehabilitation of Stroke patients should be optimal during a pandemic.
- COVID - 19
- risk factors
How to Cite
WHO. Coronavirus disease (COVID-19), Situation Report – 150 2020.
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002-11.
Siegler JE, Cardona P, Arenillas JF, Talavera B, Guillen AN, Chavarría-Miranda A, De Lera M, Khandelwal P, Bach I, Patel P. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: the SVIN COVID-19 multinational registry. International Journal of Stroke. 2020:1747493020959216.
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurology. 2020;77(11):1366-72.
Bhatia R, Srivastava MP. COVID-19 and stroke: Incidental, triggered or causative. Annals of Indian Academy of Neurology. 2020;23(3):318.
Tan Y-K, Goh C, Leow AS, Tambyah PA, Ang A, Yap E-S, Tu T-M, Sharma VK, Yeo LL, Chan BP. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. Journal of Thrombosis and Thrombolysis. 2020;50(3):587-95.
Mendes A, Herrmann FR, Genton L, Serratrice C, Carrera E, Vargas MI, Gold G, Graf CE, Zekry D, Scheffler M. Incidence, characteristics and clinical relevance of acute stroke in old patients hospitalized with COVID-19. BMC Geriatrics. 2021;21(1):1-8.
Requena M, Olivé-Gadea M, Muchada M, García-Tornel Á, Deck M, Juega J, Boned S, Rodríguez-Villatoro N, Piñana C, Pagola J. COVID-19 and stroke: incidence and etiological description in a high-volume center. Journal of Stroke and Cerebrovascular Diseases. 2020;29(11): 105225.
Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(3):247-50.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.
Oudit G, Kassiri Z, Jiang C, Liu P, Poutanen S, Penninger J, Butany J. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation. 2009;39(7):618-25.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L, Jin H, Hu B. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke and Vascular Neurology. 2020;5(3).
Kelly PJ, Murphy S, Coveney S, Purroy F, Lemmens R, Tsivgoulis G, Price C. Anti-inflammatory approaches to ischaemic stroke prevention. Journal of Neurology, Neurosurgery & Psychiatry. 2018;89(2): 211-8.
Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34(10):2518-32.
Shi K, Tian D-C, Li Z-G, Ducruet AF, Lawton MT, Shi F-D. Global brain inflammation in stroke. The Lancet Neurology. 2019;18(11):1058-66.
DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. American Journal of Hypertension. 1997;10(12):1335-41.
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317-25.
Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. New England Journal of Medicine. 2020;382(17):e38.
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD. Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): a case series. Journal of Thrombosis and Haemostasis. 2020;18(7):1752-5.
Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the brain: the renin angiotensin system. International Journal of Molecular Sciences. 2018;19(3):876.
Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? Jama. 2020;323(18):1769-70.
Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife. 2020;9:e57278.
Xia H, Lazartigues E. Angiotensin‐converting enzyme 2 in the brain: properties and future directions. Journal of Neurochemistry. 2008;107(6): 1482-94.
Fugate JE, Lyons JL, Thakur KT, Smith BR, Hedley-Whyte ET, Mateen FJ. Infectious causes of stroke. The Lancet Infectious Diseases. 2014;14(9): 869-80.
Rai N, Choudhary R, Bhatia R, Singh M, Tripathi M, Prasad K, Padma M. Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case–control study. Annals of Indian Academy of Neurology. 2011;14(2):93.
Bandaru VS, Boddu DB, Laxmi V, Neeraja M, Kaul S. Seroprevalence of Chlamydia pneumoniae antibodies in stroke in young. Canadian Journal of Neurological Sciences. 2009;36(6):725-30.
Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host & Microbe. 2013;13(4):379-93.
Desforges M, Le Coupanec A, Brison É, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Infectious Diseases and Nanomedicine I. 2014:75-96.
Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome. Rhinology. 2020;58(3):299-301.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-8.
Zhao J, Rudd A, Liu R. Challenges and potential solutions of stroke care during the coronavirus disease 2019 (COVID-19) outbreak. Am Heart Assoc; 2020.
Bhatia R, Sylaja P, Srivastava MP, Khurana D, Pandian JD, Suri V, Kumar VP, Kumaravelu S, Huded V, Surya N. Consensus statement–suggested recommendations for acute stroke management during the COVID-19 pandemic: Expert group on behalf of the Indian stroke association. Annals of Indian Academy of Neurology. 2020;23(Suppl 1):S15.
Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke. 2020;51(6):1891-5.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020.
Leadership AASC. Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910-2.
Alhazzani W, Møller M, Arabi Y, Loeb M, Gong M, Fan E, Du B. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine. 2020:1-34.
Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani-Haghighi A, Ciccone A, Gomez CR, Gurkas E, Hsu CY, Jani V. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. International Journal of Stroke. 2020;15(5):540-54.
Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, Li Y, He Q, Li M, Su Y. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke and Vascular Neurology. 2020; 5(2).
Abstract View: 90 times
PDF Download: 26 times